209 related articles for article (PubMed ID: 2215950)
1. Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Rivest J; Quinn N; Marsden CD
Neurology; 1990 Oct; 40(10):1571-8. PubMed ID: 2215950
[TBL] [Abstract][Full Text] [Related]
2. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease.
Colosimo C; Albanese A; Hughes AJ; de Bruin VM; Lees AJ
Arch Neurol; 1995 Mar; 52(3):294-8. PubMed ID: 7872884
[TBL] [Abstract][Full Text] [Related]
3. Dystonia in progressive supranuclear palsy.
Barclay CL; Lang AE
J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):352-6. PubMed ID: 9120447
[TBL] [Abstract][Full Text] [Related]
4. Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Kim JM; Jeong HJ; Bae YJ; Park SY; Kim E; Kang SY; Oh ES; Kim KJ; Jeon B; Kim SE; Cho ZH; Kim YB
Parkinsonism Relat Disord; 2016 May; 26():47-54. PubMed ID: 26951846
[TBL] [Abstract][Full Text] [Related]
5. Progressive supranuclear palsy and Parkinson's disease overlap: A clinicopathological case report.
Araki K; Sumikura H; Matsudaira T; Sugiura A; Takao M; Murayama S; Obi T
Neuropathology; 2016 Apr; 36(2):187-91. PubMed ID: 26388542
[TBL] [Abstract][Full Text] [Related]
6. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.
Leiguarda RC; Pramstaller PP; Merello M; Starkstein S; Lees AJ; Marsden CD
Brain; 1997 Jan; 120 ( Pt 1)():75-90. PubMed ID: 9055799
[TBL] [Abstract][Full Text] [Related]
7. Comparison of dystonia between Parkinson's disease and atypical parkinsonism: The clinical usefulness of dystonia distribution and characteristics in the differential diagnosis of parkinsonism.
Yoon WT
Neurol Neurochir Pol; 2018; 52(1):48-53. PubMed ID: 29196058
[TBL] [Abstract][Full Text] [Related]
8. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.
Brücke T; Asenbaum S; Pirker W; Djamshidian S; Wenger S; Wöber C; Müller C; Podreka I
J Neural Transm Suppl; 1997; 50():9-24. PubMed ID: 9120429
[TBL] [Abstract][Full Text] [Related]
9. Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy.
Stocchi F; Carbone A; Inghilleri M; Monge A; Ruggieri S; Berardelli A; Manfredi M
J Neurol Neurosurg Psychiatry; 1997 May; 62(5):507-11. PubMed ID: 9153611
[TBL] [Abstract][Full Text] [Related]
10. [Parkinson "plus"].
Fabre N; Brefel-Courbon C; Rascol O
Rev Prat; 1997 May; 47(10):1077-82. PubMed ID: 9208670
[TBL] [Abstract][Full Text] [Related]
11. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Messina D; Cerasa A; Condino F; Arabia G; Novellino F; Nicoletti G; Salsone M; Morelli M; Lanza PL; Quattrone A
Parkinsonism Relat Disord; 2011 Mar; 17(3):172-6. PubMed ID: 21236720
[TBL] [Abstract][Full Text] [Related]
12. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Bukhatwa S; Zeng BY; Rose S; Jenner P
Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
[TBL] [Abstract][Full Text] [Related]
13. Neuropathology of Parkinson's disease and related syndromes.
Gibb WR
Neurol Clin; 1992 May; 10(2):361-76. PubMed ID: 1584179
[TBL] [Abstract][Full Text] [Related]
14. Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study.
Gama RL; Távora DG; Bomfim RC; Silva CE; de Bruin VM; de Bruin PF
Parkinsonism Relat Disord; 2010 May; 16(4):275-9. PubMed ID: 20185356
[TBL] [Abstract][Full Text] [Related]
15. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease associated with argyrophilic grains clinically resembling progressive supranuclear palsy: an autopsy case.
Seno H; Kobayashi S; Inagaki T; Yamamori C; Miyaoka T; Horiguchi J; Wada M; Harada T
J Neurol Sci; 2000 Sep; 178(1):70-4. PubMed ID: 11018253
[TBL] [Abstract][Full Text] [Related]
17. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study.
Otsuka M; Ichiya Y; Kuwabara Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K
J Neurol Sci; 1996 Dec; 144(1-2):77-83. PubMed ID: 8994107
[TBL] [Abstract][Full Text] [Related]
18. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
[TBL] [Abstract][Full Text] [Related]
19. Pallido-nigro-luysian atrophy, progressive supranuclear palsy and adult onset Hallervorden-Spatz disease: a case of akinesia as a predominant feature of parkinsonism.
Yamamoto T; Kawamura J; Hashimoto S; Nakamura M; Iwamoto H; Kobashi Y; Ichijima K
J Neurol Sci; 1991 Jan; 101(1):98-106. PubMed ID: 1709202
[TBL] [Abstract][Full Text] [Related]
20. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
